Mercado mundial de carcinoides bronquiales: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado de carcinoides bronquiales

Se espera que el mercado mundial de carcinoides bronquiales experimente un crecimiento significativo durante el período de pronóstico. El tumor carcinoide es un tipo raro de trastorno maligno que se acumula en menos del 1% de todos los trastornos malignos. Aproximadamente entre 2 y 4 de cada 10 tumores carcinoides se encuentran en los pulmones. La causa de los tumores carcinoides pulmonares aún se desconoce. El aumento de casos de tumores carcinoides, carcinoma mucoepidermoide y antecedentes familiares con trastornos pulmonares impulsa el mercado de carcinoides bronquiales. COVID-19 también tuvo un gran impacto en el crecimiento del mercado.

Data Bridge Market Research analiza la tasa de crecimiento del mercado global de carcinoides bronquiales en el período de pronóstico 2022-2029. El mercado global de carcinoides bronquiales tiende a tener una CAGR saludable en el período de pronóstico mencionado. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado seleccionado por el equipo de Data Bridge Market Research también incluye un análisis profundo de expertos, epidemiología de pacientes, análisis de la cartera de proyectos, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de carcinoides bronquiales

Market Definition

Bronchial carcinoid is uncommon, rare disorder that affects 1 to 2% of all lung cancers in adults. It is a slow growing neuroendocrine tumors and low-grade malignant neoplasms rising from bronchial mucosa. Central bronchial carcinoids are common compared to the peripheral and produces symptoms including bronchial obstruction such as cough, localized wheeze, non-resolving recurrent pneumonitis, chest pain, and fever. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period.

Global Bronchial Carcinoid Market Dynamics

Drivers

• Increase in Lung Cancer

According to the GLOBOCAN 2020 estimates by the International Agency for Research on Cancer, about 19.3 million new cases of cancer recorded in 2020 and around 11.4% of them were lung cancer. Lung cancer was the primary cause of death with about 18% or 1.8 million global deaths in 2020. Thus this increasing lung cancer result in the origin of bronchial carcinoid and in return this boost the market growth.

• Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global bronchial carcinoid market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

• Increase in Geriatric Population

The elderly population is projected to increase the patient population worldwide, which boots the market in the forecast period. As per the reports of WHO, the global elderly population is anticipated to reach about 2 billion by 2050 from 617 million in 2015. The range of possibility of getting infected with varied types of cancer also rises. This boost the market growth.

• Higher Indulgence of  Advanced Therapies

The rapid growth of the biopharmaceutical industry and the increasing R&D expenses have resulted in the development of several advanced targeted therapeutics to treat lung cancer. The targeted therapy can efficiently treat cancer cells without altering the body's normal cells. This results in nominal side-effects and removes the chances of reoccurrence and deaths. The rising healthcare expenditure combined with the rising awareness associated with the availability of advanced gene therapies that can cure traditionally non-curable diseases has significantly boosted the growth of the targeted therapy across the globe. This creates more opportunities in the market.

Restraints/Challenges

• Lack of Skilled Professionals

Lack of trained professionals who are not aware of the appropriate treatment methods for this disease could restrain the growth of the global bronchial carcinoid market over a forecast period.

• High Cost

The huge expenditure of the treatment methods such as radiation therapy, chemotherapy, medications are hamper the market growth.

This global bronchial carcinoid market  report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global bronchial carcinoid market  contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Bronchial Carcinoid Market Scope

The global bronchial carcinoid market is segmented on the basis of type, treatment type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Types

• Central Bronchial Carcinoids
• Peripheral Bronchial Carcinoids
• Others

Treatment Type

• Surgery
• Radiation Therapy
• Chemotherapy
• Others

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Bronchial Carcinoid Market Regional Analysis/Insights

The global bronchial carcinoid market  is analysed and market size insights and trends are provided by type, treatment type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global bronchial carcinoid market  report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to presence of advanced technology and high R&D & healthcare expenditure.

Asia-Pacific dominates the market due to growing geriatric population suffering from lung disorder, increased usage of cigarettes & alcohol and presence of generic manufacturers.

La sección de países del informe también proporciona factores de impacto individuales en el mercado y cambios en la regulación del mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Además, se consideran la presencia y disponibilidad de marcas globales y los desafíos que enfrentan debido a la gran o escasa competencia de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales, al tiempo que se proporciona un análisis de pronóstico de los datos del país.   

Análisis del panorama competitivo y de la cuota de mercado global de carcinoides bronquiales

El panorama competitivo del mercado global de carcinoides bronquiales proporciona detalles por competidor. Los detalles incluyen una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento del producto, la amplitud y la variedad del producto, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado global de carcinoides bronquiales.

Los actores clave que operan en el mercado global de carcinoides bronquiales incluyen:

• Johnson & Johnson Private Limited (Estados Unidos)
• Cipla Inc. (Estados Unidos)
• Abbott (Estados Unidos)
• AbbVie Inc. (Estados Unidos)
• Industrias farmacéuticas Sun Ltd. (India)
• Lupino (India)
• Hikma Pharmaceuticals PLC (Reino Unido)
• Amneal Pharmaceuticals LLC. (Estados Unidos)
• Pfizer Inc (Estados Unidos)
• Mylan NV (Estados Unidos)
• Compañía Bristol-Myers Squibb (Estados Unidos)
• GSK plc. (Reino Unido)
• Bayer AG (Alemania)
• NATCO Pharma Limited (India)
• Shilpa Therapeutics Private Ltd. (India)

SKU-54193